Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
Получение большого количества дендритных клеток из культур костного мозга мыши с добавлением гранулоцитарно/макрофагального колониестимулирующего фактора.
1992-12-01
SCID: 54.1/zssxff5t
Discuss with AI
MHC class IIbone marrow culturesdendritic cellsgranulocyte/macrophage colony-stimulating factor (GM-CSF)mixed leukocyte reaction
Figures from the paper
Abstract (AI)
Antigen-presenting, major histocompatibility complex (MHC) class II-rich dendritic cells are known to arise from bone marrow. However, marrow lacks mature dendritic cells, and substantial numbers of proliferating less-mature cells have yet to be identified. The methodology for inducing dendritic cell growth that was recently described for mouse blood now has been modified to MHC class II-negative precursors in marrow. A key step is to remove the majority of nonadherent, newly formed granulocytes by gentle washes during the first 2-4 d of culture. This leaves behind proliferating clusters that are loosely attached to a more firmly adherent "stroma." At days 4-6 the clusters can be dislodged, isolated by 1-g sedimentation, and upon reculture, large numbers of dendritic cells are released. The latter are readily identified on the basis of their distinct cell shape, ultrastructure, and repertoire of antigens, as detected with a panel of monoclonal antibodies. The dendritic cells express high levels of MHC class II products and act as powerful accessory cells for initiating the mixed leukocyte reaction. Neither the clusters nor mature dendritic cells are generated if macrophage colony-stimulating factor rather than granulocyte/macrophage colony-stimulating factor (GM-CSF) is applied. Therefore, GM-CSF generates all three lineages of myeloid cells (granulocytes, macrophages, and dendritic cells). Since > 5 x 10(6) dendritic cells develop in 1 wk from precursors within the large hind limb bones of a single animal, marrow progenitors can act as a major source of dendritic cells. This feature should prove useful for future molecular and clinical studies of this otherwise trace cell type.
Key Findings
1
A modified culture method using GM-CSF on MHC class II-negative bone marrow precursors produces large numbers of dendritic cells.
2
Clusters dislodged at days 4–6 and isolated by 1-g sedimentation release mature dendritic cells identifiable by morphology, ultrastructure, and antigen repertoire.
3
Generated dendritic cells express high levels of MHC class II and function as powerful accessory cells in initiating the mixed leukocyte reaction.
4
Macrophage colony-stimulating factor (M-CSF) does not generate the clusters or mature dendritic cells, indicating GM-CSF uniquely supports granulocyte, macrophage, and dendritic lineages; a single mouse hind limb marrow yields >5×10^6 dendritic cells in one week.
5
Removing nonadherent granulocytes by gentle washes during the first 2–4 days enriches proliferating clusters that yield dendritic cells upon reculture.
Research Object
Mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor (GM-CSF)
Research Subject
Generation and expansion of large numbers of MHC class II–rich dendritic cells from marrow precursors, including culture conditions, cell yield, phenotype (morphology, ultrastructure, antigen repertoire) and functional accessory activity
Publication Details
Publication Date
1992-12-01
Journal
Publisher
ISSN
Cited by
3767
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by5
Immunobiology of Dendritic Cells2000
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting2013
Foxp3 + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation2008
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo2002
Furin‐mediated protein processing in infectious diseases and cancer2019